Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA)

NCT04795752 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye
Meibomian Gland Dysfunction

Interventions

DEVICE: TearCare System
DRUG: Cyclosporine Ophthalmic 0.05% Ophthalmic Emulsion

Sponsor

Sight Sciences, Inc.